Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients

被引：8

作者：

Moldovan, Diana ^{[1
]}

Kacso, Ina Maria ^{[1
]}

Rusu, Crina ^{[1
]}

Potra, Alina ^{[1
]}

Bondor, Cosmina Ioana ^{[2
]}

Moldovan, Ioan ^{[3
]}

Patiu, Ioan Mihai ^{[4
]}

Vladutiu, Dan ^{[1
]}

Caprioara, Mirela Gherman ^{[1
]}

机构：

[1] Univ Med & Pharm Iuliu Hatieganu, Dept Nephrol, Cluj Napoca, Romania

[2] Univ Med & Pharm Iuliu Hatieganu, Dept Stat, Cluj Napoca, Romania

[3] Emergency Mil Hosp, Cluj Napoca, Romania

[4] Nefromed Dialysis Ctr, Cluj Napoca, Romania

来源：

BIOMARKERS | 2015年 / 20卷 / 02期

关键词：

Cardiovascular disease; immunotoxicity; renal disease; CHRONIC KIDNEY-DISEASE; INTIMA-MEDIA THICKNESS; SERUM OSTEOPROTEGERIN; CARDIOVASCULAR EVENTS; FETUIN-A; ELEVATED OSTEOPROTEGERIN; CALCIFICATION INHIBITORS; PLASMA OSTEOPROTEGERIN; HEMODIALYSIS; ARTERY;

D O I：

10.3109/1354750X.2014.1000376

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To assess the osteoprotegerin (OPG) relationship with cardiovascular complications in hemodialysis (HD) patients. Methods: The study included 87 HD patients. Clinical characteristics, ankle-arm index (AAI), OPG and mineral markers levels were recorded. Arterial intimal calcification (AIC) and arterial medial calcification (AMC) were registered. Results: OPG levels were increased in HD patients. Patients with AIC (p = 0.006)/ AMC (p = 0.01) had higher OPG levels. OPG did not have any relation with cardiovascular diseases. OPG correlated positively with age, increased HD vintage and inversely with albumin and AAI. OPG has not been a risk factor for VC or cardiovascular disease. Conclusion: OPG rising could be a reaction in defense to vascular aggression, because OPG was associated with VC, but not with vascular disease.

引用

页码：116 / 122

页数：7

共 50 条

[1] Vascular Calcification in End-Stage Renal Disease Patients
Nitta, Kosaku
Ogawa, Tetsuya
CHRONIC KIDNEY DISEASES - RECENT ADVANCES IN CLINICAL AND BASIC RESEARCH, 2015, 185 : 156 - 167
[2] Perioperative Management of Patients With End-Stage Renal Disease
Kanda, Hirotsugu
Hirasaki, Yuji
Iida, Takafumi
Kanao-Kanda, Megumi
Toyama, Yuki
Chiba, Takashi
Kunisawa, Takayuki
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2017, 31 (06) : 2251 - 2267
[3] Vascular access in elderly patients with end-stage renal disease
Bessias, Nikolaos
Paraskevas, Kosmas I.
Tziviskou, Effie
Andrikopoulos, Vassilios
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (04) : 1133 - 1142
[4] Vascular access in elderly patients with end-stage renal disease
Nikolaos Bessias
Kosmas I. Paraskevas
Effie Tziviskou
Vassilios Andrikopoulos
International Urology and Nephrology, 2008, 40 : 1133 - 1142
[5] Recent Advances in the Management of Vascular Calcification in Patients with End-Stage Renal Disease
Nitta, Kosaku
Ogawa, Tetsuya
Hanafusa, Norio
Tsuchiya, Ken
CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 62 - 72
[6] Adiponectin and end-stage renal disease
Markaki, Anastasia
Psylinakis, Emmanuel
Spyridaki, Aspasia
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 15 (03): : 345 - 354
[7] Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
Roumeliotis, Stefanos
Roumeliotis, Athanasios
Dounousi, Evangelia
Eleftheriadis, Theodoros
Liakopoulos, Vassilios
CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (01) : 77 - 90
[8] Vascular calcification in end-stage renal disease
Jablonski, Kristen L.
Chonchol, Michel
HEMODIALYSIS INTERNATIONAL, 2013, 17 : S17 - S21
[9] Safety and Efficacy of Statins in Patients With End-Stage Renal Disease
Nemerovski, Carrie W.
Lekura, Jona
Cefaretti, Michelle
Mehta, Pooja T.
Moore, Carol L.
ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1321 - 1329
[10] Vascular calcification in a young patient with end-stage renal disease
Chan, Winnie K. Y.
Lee, K. W.
But, W. M.
Chau, K. F.
HONG KONG MEDICAL JOURNAL, 2013, 19 (02) : 178 - 181

← 1 2 3 4 5 →